Cargando…

Requirement of Fas for the Development of Autoimmune Diabetes in Nonobese Diabetic Mice

Insulin-dependent diabetes mellitus (IDDM) is assumed to be a T cell–mediated autoimmune disease. To investigate the role of Fas-mediated cytotoxicity in pancreatic β cell destruction, we established nonobese diabetic (NOD)-lymphoproliferation (lpr)/lpr mice lacking Fas. Out of three genotypes, fema...

Descripción completa

Detalles Bibliográficos
Autores principales: Itoh, Naoto, Imagawa, Akihisa, Hanafusa, Toshiaki, Waguri, Masako, Yamamoto, Koji, Iwahashi, Hiromi, Moriwaki, Makoto, Nakajima, Hiromu, Miyagawa, Junichiro, Namba, Mitsuyoshi, Makino, Susumu, Nagata, Shigekazu, Kono, Norio, Matsuzawa, Yuji
Formato: Texto
Lenguaje:English
Publicado: The Rockefeller University Press 1997
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2199040/
https://www.ncbi.nlm.nih.gov/pubmed/9254659
_version_ 1782148120066392064
author Itoh, Naoto
Imagawa, Akihisa
Hanafusa, Toshiaki
Waguri, Masako
Yamamoto, Koji
Iwahashi, Hiromi
Moriwaki, Makoto
Nakajima, Hiromu
Miyagawa, Junichiro
Namba, Mitsuyoshi
Makino, Susumu
Nagata, Shigekazu
Kono, Norio
Matsuzawa, Yuji
author_facet Itoh, Naoto
Imagawa, Akihisa
Hanafusa, Toshiaki
Waguri, Masako
Yamamoto, Koji
Iwahashi, Hiromi
Moriwaki, Makoto
Nakajima, Hiromu
Miyagawa, Junichiro
Namba, Mitsuyoshi
Makino, Susumu
Nagata, Shigekazu
Kono, Norio
Matsuzawa, Yuji
author_sort Itoh, Naoto
collection PubMed
description Insulin-dependent diabetes mellitus (IDDM) is assumed to be a T cell–mediated autoimmune disease. To investigate the role of Fas-mediated cytotoxicity in pancreatic β cell destruction, we established nonobese diabetic (NOD)-lymphoproliferation (lpr)/lpr mice lacking Fas. Out of three genotypes, female NOD-+/+ and NOD-+/lpr developed spontaneous diabetes by the age of 10 mo with the incidence of 68 and 62%, respectively. In contrast, NOD-lpr/lpr did not develop diabetes or insulitis. To further explore the role of Fas, adoptive transfer experiments were performed. When splenocytes were transferred from diabetic NOD, male NOD-+/+ and NOD-+/lpr developed diabetes with the incidence of 89 and 83%, respectively, whereas NOD-lpr/lpr did not show glycosuria by 12 wk after transfer. Severe mononuclear cell infiltration was revealed in islets of NOD-+/+ and NOD-+/lpr, whereas islet morphology remained intact in NOD-lpr/lpr. These results suggest that Fas-mediated cytotoxicity is required to initiate β cell autoimmunity in NOD mice. Fas–Fas ligand system might be critical for autoimmune β cell destruction leading to IDDM.
format Text
id pubmed-2199040
institution National Center for Biotechnology Information
language English
publishDate 1997
publisher The Rockefeller University Press
record_format MEDLINE/PubMed
spelling pubmed-21990402008-04-16 Requirement of Fas for the Development of Autoimmune Diabetes in Nonobese Diabetic Mice Itoh, Naoto Imagawa, Akihisa Hanafusa, Toshiaki Waguri, Masako Yamamoto, Koji Iwahashi, Hiromi Moriwaki, Makoto Nakajima, Hiromu Miyagawa, Junichiro Namba, Mitsuyoshi Makino, Susumu Nagata, Shigekazu Kono, Norio Matsuzawa, Yuji J Exp Med Brief Definitive Report Insulin-dependent diabetes mellitus (IDDM) is assumed to be a T cell–mediated autoimmune disease. To investigate the role of Fas-mediated cytotoxicity in pancreatic β cell destruction, we established nonobese diabetic (NOD)-lymphoproliferation (lpr)/lpr mice lacking Fas. Out of three genotypes, female NOD-+/+ and NOD-+/lpr developed spontaneous diabetes by the age of 10 mo with the incidence of 68 and 62%, respectively. In contrast, NOD-lpr/lpr did not develop diabetes or insulitis. To further explore the role of Fas, adoptive transfer experiments were performed. When splenocytes were transferred from diabetic NOD, male NOD-+/+ and NOD-+/lpr developed diabetes with the incidence of 89 and 83%, respectively, whereas NOD-lpr/lpr did not show glycosuria by 12 wk after transfer. Severe mononuclear cell infiltration was revealed in islets of NOD-+/+ and NOD-+/lpr, whereas islet morphology remained intact in NOD-lpr/lpr. These results suggest that Fas-mediated cytotoxicity is required to initiate β cell autoimmunity in NOD mice. Fas–Fas ligand system might be critical for autoimmune β cell destruction leading to IDDM. The Rockefeller University Press 1997-08-18 /pmc/articles/PMC2199040/ /pubmed/9254659 Text en This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/4.0/).
spellingShingle Brief Definitive Report
Itoh, Naoto
Imagawa, Akihisa
Hanafusa, Toshiaki
Waguri, Masako
Yamamoto, Koji
Iwahashi, Hiromi
Moriwaki, Makoto
Nakajima, Hiromu
Miyagawa, Junichiro
Namba, Mitsuyoshi
Makino, Susumu
Nagata, Shigekazu
Kono, Norio
Matsuzawa, Yuji
Requirement of Fas for the Development of Autoimmune Diabetes in Nonobese Diabetic Mice
title Requirement of Fas for the Development of Autoimmune Diabetes in Nonobese Diabetic Mice
title_full Requirement of Fas for the Development of Autoimmune Diabetes in Nonobese Diabetic Mice
title_fullStr Requirement of Fas for the Development of Autoimmune Diabetes in Nonobese Diabetic Mice
title_full_unstemmed Requirement of Fas for the Development of Autoimmune Diabetes in Nonobese Diabetic Mice
title_short Requirement of Fas for the Development of Autoimmune Diabetes in Nonobese Diabetic Mice
title_sort requirement of fas for the development of autoimmune diabetes in nonobese diabetic mice
topic Brief Definitive Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2199040/
https://www.ncbi.nlm.nih.gov/pubmed/9254659
work_keys_str_mv AT itohnaoto requirementoffasforthedevelopmentofautoimmunediabetesinnonobesediabeticmice
AT imagawaakihisa requirementoffasforthedevelopmentofautoimmunediabetesinnonobesediabeticmice
AT hanafusatoshiaki requirementoffasforthedevelopmentofautoimmunediabetesinnonobesediabeticmice
AT wagurimasako requirementoffasforthedevelopmentofautoimmunediabetesinnonobesediabeticmice
AT yamamotokoji requirementoffasforthedevelopmentofautoimmunediabetesinnonobesediabeticmice
AT iwahashihiromi requirementoffasforthedevelopmentofautoimmunediabetesinnonobesediabeticmice
AT moriwakimakoto requirementoffasforthedevelopmentofautoimmunediabetesinnonobesediabeticmice
AT nakajimahiromu requirementoffasforthedevelopmentofautoimmunediabetesinnonobesediabeticmice
AT miyagawajunichiro requirementoffasforthedevelopmentofautoimmunediabetesinnonobesediabeticmice
AT nambamitsuyoshi requirementoffasforthedevelopmentofautoimmunediabetesinnonobesediabeticmice
AT makinosusumu requirementoffasforthedevelopmentofautoimmunediabetesinnonobesediabeticmice
AT nagatashigekazu requirementoffasforthedevelopmentofautoimmunediabetesinnonobesediabeticmice
AT kononorio requirementoffasforthedevelopmentofautoimmunediabetesinnonobesediabeticmice
AT matsuzawayuji requirementoffasforthedevelopmentofautoimmunediabetesinnonobesediabeticmice